Evidence map›Paper›PMID 25516026›Full record

ArticleJournal of the American Geriatrics Society2014

Associations between inflammation and cognitive function in African Americans and European Americans.

B Gwen Windham, Brittany N Simpson, Seth Lirette, John Bridges, Lawrence Bielak, Patricia A Peyser, Iftikhar Kullo, Stephen Turner, Michael E Griswold, Thomas H Mosley

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07284316 (Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance), which is not on this map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07284316 phase2 / phase3active not recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance: A Randomized Clinical Trial

TypeinterventionalSponsorInstituto Mexicano del Seguro SocialRan2025 to 2027Enrolled100ConditionsCognitive Decline, Subjective Cognitive Impairment, Insulin ResistanceArmsTurmeric extract, Control: Placebo. 500mg gelatin in capsules 2 times a day
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Circulating Mediators of Apoptosis and Inflammation in Aging; Physical Exercise Intervention.International journal of environmental research and public health · 2021
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Reply to YasumaAmerican journal of respiratory and critical care medicine · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

B Gwen WindhamDivision of Geriatric Medicine, Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.
Brittany N Simpson
Seth Lirette
John Bridges
Lawrence Bielak
Patricia A Peyser
Iftikhar Kullo
Stephen Turner
Michael E Griswold
Thomas H Mosley
University of Mississippi Medical Center · USMayo Clinic · USMichigan United · USUniversity of Michigan–Ann Arbor · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Genetics of Microangiopathic Brain InjuryR01NS041558 · NINDS · MAYO CLINIC ROCHESTER · PI TURNER, STEPHEN T · 2001 to 2010
$5.8M
Genomic Predictors of Arteriosclerosis in HypertensivesR01HL087660 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARDIA, SHARON L · 2007 to 2009
$5.1M
Proteomic Markers of ArteriosclerosisU01HL081331 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2005 to 2008
$3.7M
GENETIC DETERMINANTS OF HIGH BLOOD PRESSURE (GENOA)U01HL054463 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI MOSLEY, THOMAS H · 2000 to 2004
$1.6M
NCRR NIH HHS M01 RR000585NCRR NIH HHS M01 RR00585NHLBI NIH HHS HL-81331NHLBI NIH HHS R01 HL087660NHLBI NIH HHS R01-HL87660NHLBI NIH HHS U01 HL054463NHLBI NIH HHS U01-HL054463NHLBI NIH HHS U01 HL081331NINDS NIH HHS R01 NS041558
6 · The paper itself

Abstract

objectivesTo examine associations between specific inflammatory biomarkers and cognitive function in African Americans (AAs) and European Americans (EAs) with prevalent vascular risk factors.

designCross-sectional analysis using generalized estimating equations to account for familial clustering; standardized β-coefficients, adjusted for age, sex, and education are reported.

settingCommunity cohort study in Jackson, Mississippi, and Rochester, Minnesota.

participantsGenetic Epidemiology Network of Arteriopathy (GENOA)-Genetics of Microangiopathic Brain Injury (GMBI) Study participants. MEASUREMENTS: Associations between inflammation (high-sensitivity C-reactive protein (CRP), interleukin (IL)-6, soluble tumor necrosis factor (TNF) receptor 1 and 2 (sTNFR1, sTNFR2)) and cognitive function (global, processing speed, language, memory, and executive function) were examined in AAs and EAs (N = 1,965; aged 26-95, 64% women, 52% AA, 75% with hypertension).

resultsIn AAs, higher sTNFR2 was associated with poorer cognition in all domains (global: -0.11, P = .009; processing speed: -0.11, P < .001; language: -0.08, P = .002; memory: -0.09, P = .008; executive function: -0.07, P = .03); sTNFR1 was associated with slower processing speed (-0.08, P < .001) and poorer executive function (-0.08, P = .008); higher CRP was associated with slower processing speed (-0.04, P = .024), and higher IL6 was associated with poorer executive function (-0.07, P = .02). In EA, only higher sTNFR1 was associated with slower processing speed (-0.05, P = .007). Associations were not found between cognition and sTNFR2, CRP, or IL6 in EA.

conclusionIn a population with high vascular risk, adverse associations between inflammation and cognitive function were especially apparent in AAs, primarily involving markers of TNFα activity.

Indexed as

Black or African AmericanWhite PeopleBiomarkersCognition DisordersC-Reactive ProteinFemaleHumansInflammationInterleukin-6MaleMiddle AgedMinnesotaMississippiReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRisk FactorsBiomarkersC-Reactive ProteinInterleukin-6Receptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIcognitionethnicityinflammation

Identifiers

PMID25516026
PMCPMC4270090
OpenAlexW2035681228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.